Endo ERN
Find an expert
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

890 publication(s) found matching the search criteria

Clinical considerations for the treatment of secondary differentiated thyroid carcinoma in childhood cancer survivors


Author(s): van Santen HM, Alexander EK, Rivkees SA, Frey E, Clement SC, Dierselhuis MP, Lebbink CA, Links TP, Lorenz K, Peeters RP, Reiners C, Vriens MR, Nathan P, Schneider AB, Verburg F
Affiliated Institution / ERN:
Condition / Disease: Follicular thyroid carcinoma
Publication: European Journal of Endocrinology v183.3 pP1-P10 Year: 2020 ORPHAcode / other: ORPHA146
DOI: 10.1530/EJE-20-0237 Keywords:
MTG8

HDL Cholesterol Efflux Capacity is Impaired in Severe Short-Term Hypothyroidism Despite Increased HDL Cholesterol


Author(s): van der Boom T, Jia C, Lefrandt JD, Connelly MA, Links TP, Tietge UJF, Dullaart RPF
Affiliated Institution / ERN:
Condition / Disease: Follicular thyroid carcinoma
Publication: The Journal of Clinical Endocrinology & Metabolism v105.9 pe3355-e3362 Year: 2020 ORPHAcode / other: ORPHA146
DOI: 10.1210/clinem/dgaa411 Keywords: HDL ant-oxidative capacity,HDL cholesterol,HDL subfractions,cholesterol efflux capacity,hypothyroidism,nuclear magnetic resonance
MTG8

Approach to the Patient: Perioperative Management of the Patient with Pheochromocytoma or Sympathetic Paraganglioma


Author(s): Berends AMA, Kerstens MN, Lenders JWM, Timmers HJLM
Affiliated Institution / ERN: University Hospital Essen ; Sestre milosrdnice University Hospital Center ;
Condition / Disease: Pheochromocytoma and paraganglioma
Publication: The Journal of Clinical Endocrinology & Metabolism v105.9 p3088-3102 Year: 2020 ORPHAcode / other: ORPHA573163
DOI: 10.1210/clinem/dgaa441 Keywords: alpha-receptor blockade,perioperative management,pheochromocytoma,sympathetic paraganglioma
MTG1 MTG4

Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly


Author(s): Coopmans EC, Korevaar TIM, van Meyel SWF, Daly AF, Chanson P, Brue T, Delemer B, Hána V, Colao A, Carvalho D, Jaffrain-Rea M, Stalla GK, Fajardo-Montañana C, Beckers A, van der Lely AJ, Petrossians P, Neggers SJCMM
Affiliated Institution / ERN:
Condition / Disease: Central congenital hypothyroidism
Publication: The Journal of Clinical Endocrinology & Metabolism v105.9 p2964-2974 Year: 2020 ORPHAcode / other: ORPHA226298
DOI: 10.1210/clinem/dgaa387 Keywords: acromegaly,biochemical response,first-generation somatostatin receptor ligands
MTG8

Hyperprolactinemia in Acromegaly is Related to Prolactin Secretion by Somatolactotroph Tumours


Author(s): Van Laethem D, Michotte A, Cools W, Velkeniers B, Unuane D, Andreescu CE, Bravenboer B
Affiliated Institution / ERN:
Condition / Disease: Acromegaly
Publication: Hormone and Metabolic Research v52.09 p647-653 Year: 2020 ORPHAcode / other: ORPHA963
DOI: 10.1055/a-1207-1132 Keywords:
MTG6

Psychosexual Outcome, Sexual Function, and Long-Term Satisfaction of Adolescent and Young Adult Men After Childhood Hypospadias Repair


Author(s): Tack LJ, Springer A, Riedl S, Tonnhofer U, Weninger J, Hiess M, Van Laecke E, Hoebeke P, Spinoit A, Cools M, Van Hoecke E
Affiliated Institution / ERN:
Condition / Disease: Other
Publication: The Journal of Sexual Medicine v17.9 p1665-1675 Year: 2020 ORPHAcode / other: ORPHA98085
DOI: 10.1016/j.jsxm.2020.04.002 Keywords: Erectile Function,Hypospadias,Hypospadias Repair,Psychosexual Outcome,Sexual Function
MTG7

Pancreatic Neuroendocrine Neoplasms: Does Sex Matter?


Author(s): Muscogiuri G, Barrea L, Feola T, Gallo M, Messina E, Venneri MA, Faggiano A, Colao A
Affiliated Institution / ERN:
Condition / Disease:
Publication: Trends in Endocrinology & Metabolism v31.9 p631-641 Year: 2020 ORPHAcode / other:
DOI: 10.1016/j.tem.2020.02.010 Keywords: epidemiology,pancreatic neuroendocrine neoplasms,sex,sex difference

Comparative meta‐analysis of Kabuki syndrome with and without hyperinsulinaemic hypoglycaemia


Author(s): Hoermann H, El‐Rifai O, Schebek M, Lodefalk M, Brusgaard K, Bachmann N, Bergmann C, Roeper M, Welters A, Salimi Dafsari R, Blankenstein O, Mayatepek E, Christesen H, Meissner T, Kummer S
Affiliated Institution / ERN: Universitätsklinikum Düsseldorf ; Charité Universitätsmedizin Berlin ; Odense University Hospital ;
Condition / Disease: Diazoxide-sensitive diffuse hyperinsulinism
Publication: Clinical Endocrinology v93.3 p346-354 Year: 2020 ORPHAcode / other: ORPHA165985
DOI: 10.1111/cen.14267 Keywords: KDM6A,KMT2D,Kabuki syndrome,diazoxide,hyperinsulinism,hypoglycaemia,medical genetics
MTG3

Neonatal diabetes due to potassium channel mutation: Response to sulfonylurea according to the genotype


Author(s): Garcin L, Mericq V, Fauret‐Amsellem A, Cave H, Polak M, Beltrand J
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ;
Condition / Disease: Neonatal diabetes
Publication: Pediatric Diabetes v21.6 p932-941 Year: 2020 ORPHAcode / other: ORPHA224
DOI: 10.1111/pedi.13041 Keywords: genotype-phenotype correlation,monogenic diabetes,precision medicine
MTG3

GnRH Deficient Patients With Congenital Hypogonadotropic Hypogonadism: Novel Genetic Findings in ANOS1, RNF216, WDR11, FGFR1, CHD7, and POLR3A Genes in a Case Series and Review of the Literature


Author(s): Neocleous V, Fanis P, Toumba M, Tanteles GA, Schiza M, Cinarli F, Nicolaides NC, Oulas A, Spyrou GM, Mantzoros CS, Vlachakis D, Skordis N, Phylactou LA
Affiliated Institution / ERN:
Condition / Disease: Congenital hypogonadotropic hypogonadism
Publication: Frontiers in Endocrinology v11 Year: 2020 ORPHAcode / other: ORPHA174590
DOI: 10.3389/fendo.2020.00626 Keywords: GnRH,digenic inheritance,genes,hypogonadotropic hypogonadism,next generation sequencing
MTG6

PD-1 Blockade in Anaplastic Thyroid Carcinoma


Author(s): Capdevila J, Wirth LJ, Ernst T, Ponce Aix S, Lin C, Ramlau R, Butler MO, Delord J, Gelderblom H, Ascierto PA, Fasolo A, Führer D, Hütter-Krönke ML, Forde PM, Wrona A, Santoro A, Sadow PM, Szpakowski S, Wu H, Bostel G, Faris J, Cameron S, Varga A, Taylor M
Affiliated Institution / ERN: Hôpital Universitaire de Bruxelles (HUDERF-Erasme) ;
Condition / Disease: Anaplastic Thyroid Carcinoma
Publication: Journal of Clinical Oncology v38.23 p2620-2627 Year: 2020 ORPHAcode / other: ORPHA142
DOI: 10.1200/JCO.19.02727 Keywords:
MTG8

Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients


Author(s): Giovanna Mantovani, Murat Bastepe, David Monk, Luisa de Sanctis, Susanne Thiele, S Faisal Ahmed, Roberto Bufo, Timothée Choplin, Gianpaolo De Filippo, Guillemette Devernois, Thomas Eggermann, Francesca M Elli, Aurora Garcia Ramirez, Emily L Germain-Lee, Lionel Groussin, Neveen AT Hamdy, Patrick Hanna, Olaf Hiort, Harald Jüppner, Peter Kamenický, Nina Knight, Elvire Le Norcy, Beatriz Lecumberri, Michael A Levine, Outi Mäkitie, Regina Martin, Gabriel Ángel Martos-Moreno, Manasori Minagawa, Philip Murray, Arrate Pereda, Robert Pignolo, Lars Rejnmark, Rebeca Rodado, Anya Rothenbuhler, Vrinda Saraff, Ashley H Shoemaker, Eileen M Shore, Caroline Silve, Serap Turan, Philip Woods, M Carola Zillikens, Guiomar Perez de Nanclares, Agnès Linglart
Affiliated Institution / ERN: Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ; AO City of Health and Science - Turin ; Universitätsklinikum Schleswig-Holstein ; Hôpital Bicêtre ; University Hospital Aachen ; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ; Leiden University Medical Center ; Helsinki University Hospital (HUS) ; Aarhus University Hospital ; Erasmus MC: University Medical Center Rotterdam ;
Condition / Disease:
Publication: Karger DOI 10.1159/000508985 Year: 2020 ORPHAcode / other:
DOI: Keywords:
MTG2

Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective


Author(s): Muscogiuri G, Altieri B, Albertelli M, Dotto A, Modica R, Barrea L, Fanciulli G, Feola T, Baldelli R, Ruggeri RM, Gallo M, Guarnotta V, Malandrino P, Messina E, Venneri MA, Giannetta E, Ferone D, Colao A, Faggiano A
Affiliated Institution / ERN: ERN BOND ;
Condition / Disease: Pancreatic neuroendocrine neoplasms
Publication: Endocrine v69.2 p441-450 Year: 2020 ORPHAcode / other: ORPHA97253
DOI: 10.1007/s12020-020-02331-3 Keywords: Cardiovascular diseases,Epidemiology,Gender,Pancreatic neuroendocrine neoplasms,Sex,Type 2 diabetes

ENDOCRINOLOGY IN THE TIME OF COVID-19: Clinical management of neuroendocrine neoplasms (NENs)


Author(s): Ruth T Casey, Gerlof D Valk, Camilla Schalin-Jäntti, Ashley B Grossman Rajesh V Thakker
Affiliated Institution / ERN: ERN BOND ;
Condition / Disease: Neuroendocrine neoplasm
Publication: European Journal of Endocrinology Volume 183: Issue 2 Page(s): G79-G88 Year: 2020 ORPHAcode / other: ORPHA877
DOI: 10.1530/EJE-20-0424 Keywords: COVID-19; neuroendocrine neoplasms; treatment;

Adrenal Crisis May Occur Even In Patients With Asymptomatic Covid-19


Author(s): Castinetti F, Amodru V, Brue T
Affiliated Institution / ERN:
Condition / Disease: Acute Adrenal Insufficiency
Publication: Endocrine Practice v26.8 p929-930 Year: 2020 ORPHAcode / other: ORPHA95409
DOI: 10.4158/1934-2403-26.8.929 Keywords:
MTG1

Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents


Author(s): Cherubini V, Grimsmann JM, Åkesson K, Birkebæk NH, Cinek O, Dovč K, Gesuita R, Gregory JW, Hanas R, Hofer SE, Holl RW, Jefferies C, Joner G, King BR, Mayer-Davis EJ, Peña AS, Rami-Merhar B, Schierloh U, Skrivarhaug T, Sumnik Z, Svensson J, Warner JT, Bratina N, Dabelea D
Affiliated Institution / ERN:
Condition / Disease: Type 1 Diabetes Mellitus
Publication: Diabetologia v63.8 p1530-1541 Year: 2020 ORPHAcode / other: 5A10
DOI: 10.1007/s00125-020-05152-1 Keywords: Children with diabetes,Complications,Diabetic ketoacidosis,Diagnosis of diabetes,Epidemiology,Type 1 diabetes
MTG3

Efficacy and safety of dopamine agonists in patients treated with antipsychotics and presenting a macroprolactinoma


Author(s): Allard L, Albarel F, Bertherat J, Caron PJ, Cortet C, Courtillot C, Delemer B, Jublanc C, Maiter D, Nunes ML, Raverot G, Sarfati J, Salenave S, Corruble E, Choucha W, Chanson P
Affiliated Institution / ERN:
Condition / Disease: Prolactinoma
Publication: European Journal of Endocrinology v183.2 p221-231 Year: 2020 ORPHAcode / other: ORPHA2965
DOI: 10.1530/EJE-20-0125 Keywords:
MTG6

Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension


Author(s): Lenders JW, Kerstens MN, Amar L, Prejbisz A, Robledo M, Taieb D, Pacak K, Crona J, Zelinka T, Mannelli M, Deutschbein T, Timmers HJ, Castinetti F, Dralle H, Widimský J, Gimenez-Roqueplo A, Eisenhofer G
Affiliated Institution / ERN: Sestre milosrdnice University Hospital Center ; University Hospital Essen ; IRCCS Istituto Giannina Gaslini, Genova ; Clinical Psychiatric Hospital "Alexandru Obregia" ; CHU d'Angers ; Children's Clinical University Hospital, Riga ;
Condition / Disease: Phaeochromocytoma and paraganglioma
Publication: Journal of Hypertension v38.8 p1443-1456 Year: 2020 ORPHAcode / other: ORPHA573163
DOI: 10.1097/hjh.0000000000002438 Keywords:
MTG1 MTG4

Etomidate infusion at low doses is an effective and safe treatment for severe Cushing’s syndrome outside intensive care


Author(s): Constantinescu SM, Driessens N, Lefebvre A, Furnica RM, Corvilain B, Maiter D
Affiliated Institution / ERN: Hôpital Universitaire de Bruxelles (HUDERF-Erasme) ; University Hospitals Saint-Luc ;
Condition / Disease: Cushing syndrome due to cortisol-producing adrenocortical adenoma
Publication: European Journal of Endocrinology v183.2 p161-167 Year: 2020 ORPHAcode / other: ORPHA647758
DOI: DOI: 10.1530/EJE-20-0380 Keywords:
MTG1 MTG6

Presentation and outcome of subsequent thyroid cancer among childhood cancer survivors compared to sporadic thyroid cancer: a matched national study


Author(s): Clement SC, Lebbink CA, Klein Hesselink MS, Teepen JC, Links TP, Ronckers CM, van Santen HM
Affiliated Institution / ERN:
Condition / Disease: Follicular thyroid carcinoma
Publication: European Journal of Endocrinology v183.2 p169-180 Year: 2020 ORPHAcode / other: ORPHA146
DOI: 10.1530/EJE-20-0153 Keywords:
MTG8

Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma


Author(s): Nies M, Cantineau AE, Arts EG, van den Berg MH, van Leeuwen FE, Muller Kobold AC, Klein Hesselink MS, Burgerhof JG, Brouwers AH, van Dam EW, Havekes B, van den Heuvel-Eibrink MM, Corssmit EP, Kremer LC, Netea-Maier RT, van der Pal HJ, Peeters RP, Plukker JT, Ronckers CM, van Santen HM, van der Horst-Schrivers AN, Tissing WJ, Bocca G, van Dulmen-den Broeder E, Links TP
Affiliated Institution / ERN:
Condition / Disease: Follicular thyroid carcinoma
Publication: Thyroid v30.8 p1169-1176 Year: 2020 ORPHAcode / other: ORPHA146
DOI: 10.1089/thy.2019.0560 Keywords: adverse effects,childhood cancer,differentiated thyroid carcinoma,fertility,radioiodine
MTG8

HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA)


Author(s): Vasilev V, Daly AF, Trivellin G, Stratakis CA, Zacharieva S, Beckers A
Affiliated Institution / ERN:
Condition / Disease: Familial isolated pituitary adenoma
Publication: Endocrine-Related Cancer v27.8 pT77-T86 Year: 2020 ORPHAcode / other: ORPHA314777
DOI: 10.1530/ERC-20-0015 Keywords: AIP,FIPA,GPR101,X-linked acrogigantism,familial isolated pituitary adenomas,pituitary adenoma
MTG6

Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature


Author(s): Lizzul L, Lombardi G, Barbot M, Ceccato F, Gardiman MP, Regazzo D, Bellu L, Mazza E, Losa M, Scaroni C
Affiliated Institution / ERN:
Condition / Disease: Pituitary adenoma
Publication: Pituitary v23.4 p359-366 Year: 2020 ORPHAcode / other: ORPHA99408
DOI: 10.1007/s11102-020-01040-4 Keywords: Aggressive pituitary adenoma,PitNETs,Pituitary carcinoma,Pituitary tumors,Temozolomide
MTG6

Two Novel Cases of Resistance to Thyroid Hormone Due to THRA Mutation


Author(s): le Maire A, Bouhours-Nouet N, Soamalala J, Mirebeau-Prunier D, Paloni M, Guee L, Heron D, Mignot C, Illouz F, Joubert F, Briet C, Rodien P, Bourguet W, Flamant F, Guyot R
Affiliated Institution / ERN:
Condition / Disease: Thyroid hormone resistance syndromes
Publication: Thyroid v30.8 p1217-1221 Year: 2020 ORPHAcode / other: ORPHA596426
DOI: 10.1089/thy.2019.0602 Keywords: genetic disease,nuclear receptor,thyroid hormone
MTG8

Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment


Author(s): Bianchi ML, Bishop NJ, Guañabens N, Hofmann C, Jakob F, Roux C, Zillikens MC
Affiliated Institution / ERN: ERN BOND ; IRCCS Auxologico Italian Institute - Milan ; University Hospital Würzburg ; Erasmus MC: University Medical Center Rotterdam ;
Condition / Disease: Hypophosphatasia
Publication: Osteoporosis International v31.8 p1445-1460 Year: 2020 ORPHAcode / other:
DOI: 10.1007/s00198-020-05345-9 Keywords: Alkaline phosphatase,Bone,Fractures,Hypomineralization,Hypophosphatasia,Teeth

COVID-19 and Cushing’s syndrome: recommendations for a special population with endogenous glucocorticoid excess


Author(s): Pivonello R, Ferrigno R, Isidori AM, Biller BMK, Grossman AB, Colao A
Affiliated Institution / ERN:
Condition / Disease: Cushing’s Syndrome
Publication: The Lancet Diabetes & Endocrinology v8.8 p654-656 Year: 2020 ORPHAcode / other: ORPHA553
DOI: 10.1016/S2213-8587(20)30215-1 Keywords:
MTG1 MTG6

Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas


Author(s): Vasilev V, Daly AF, Zacharieva S, Beckers A
Affiliated Institution / ERN:
Condition / Disease: Pituitary adenoma
Publication: Hormone and Metabolic Research v52.08 p553-561 Year: 2020 ORPHAcode / other: ORPHA99408
DOI: 10.1055/a-1143-5930 Keywords:
MTG6

Editorial: Health-Related Complications of Acromegaly


Author(s): Bolanowski M, Boguszewski CL, Colao A, Jawiarczyk-Przybyłowska A
Affiliated Institution / ERN: AOU Federico II - Naples ;
Condition / Disease: Acromegaly
Publication: Frontiers in Endocrinology v11 Year: 2020 ORPHAcode / other: ORPHA963
DOI: 10.3389/fendo.2020.00496 Keywords: acromegaly,complications,endothelium,fractures,hypertension,insulin resistance,neoplasm,quality of life
MTG6

The Impact of the Extent of Surgery on the Long-Term Outcomes of Patients with Low-Risk Differentiated Non-Medullary Thyroid Cancer: A Systematic Meta-Analysis


Author(s): Bojoga A, Koot A, Bonenkamp J, de Wilt J, IntHout J, Stalmeier P, Hermens R, Smit J, Ottevanger P, Netea-Maier R
Affiliated Institution / ERN:
Condition / Disease: Follicular thyroid carcinoma
Publication: Journal of Clinical Medicine v9.7 p2316 Year: 2020 ORPHAcode / other: ORPHA146
DOI: https://doi.org/10.3390/jcm9072316 Keywords: low-risk thyroid cancer; thyroid lobectomy; total thyroidectomy; shared decision making;
MTG8

Phase Angle: Could Be an Easy Tool to Detect Low-Grade Systemic Inflammation in Adults Affected by Prader–Willi Syndrome?


Author(s): Barrea L, Pugliese G, de Alteriis G, Colao A, Savastano S, Muscogiuri G
Affiliated Institution / ERN:
Condition / Disease: Prader-Willi syndrome
Publication: Nutrients v12.7 p2065 Year: 2020 ORPHAcode / other: ORPHA739
DOI: 10.3390/nu12072065 Keywords: Prader–Willi syndrome,chronic low-grade inflammation,nutritionist,obesity,phase angle
MTG5
Page 26 of 30« First«...1020...2425262728...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2025. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance